论文部分内容阅读
采用酶联免疫吸附法（ＥＬＩＳＡ）检测了９７例各型肝病及２８名健康人血清中的可溶性白细胞介素－２受体（ＳＩＬ—２Ｒ）水平。结果显示：各型肝病病人血清中的ＳＩＬ—２Ｒ水平均高于对照组；除轻度慢性肝炎组外，各组病人血清ＳＩＬ—２Ｒ水平均显著高于对照组，差异有高度显著性（Ｐ＜０．０１）；轻度慢性肝炎组与其余各组的差异亦有高度显著性（Ｐ＜０．０１）；除轻度慢性肝炎组外，共余各组间差异无显著性（Ｐ＞０．０５）。
Serum levels of soluble interleukin-2 receptor (SIL-2R) were measured in 97 liver cirrhosis patients and 28 healthy individuals by enzyme-linked immunosorbent assay (ELISA). The results showed that the levels of serum SIL-2R in patients with liver disease were higher than those in the control group. The levels of serum SIL-2R in patients with mild chronic hepatitis were significantly higher than those in the control group (P <0.01). There was also a significant difference between mild chronic hepatitis group and other groups (P <0.01). There was no significant difference except mild chronic hepatitis group (P> 0.05).